[go: up one dir, main page]

HK1197267A1 - 分離的腎細胞及其用途 - Google Patents

分離的腎細胞及其用途

Info

Publication number
HK1197267A1
HK1197267A1 HK14110826A HK14110826A HK1197267A1 HK 1197267 A1 HK1197267 A1 HK 1197267A1 HK 14110826 A HK14110826 A HK 14110826A HK 14110826 A HK14110826 A HK 14110826A HK 1197267 A1 HK1197267 A1 HK 1197267A1
Authority
HK
Hong Kong
Prior art keywords
renal cells
isolated renal
isolated
cells
renal
Prior art date
Application number
HK14110826A
Other languages
English (en)
Inventor
沙倫．普里斯內爾
安德魯．布魯斯
謝伊．
．華萊士
蘇瑪納．喬德赫里
拉塞爾．
．凱利
曼紐爾．
．杰奧
埃里克．
．沃丁
帕特里夏．
．塔特蘇米
杰西卡．
．萊因施
蒂莫西．
．伯特拉姆
奧魯瓦托英．
．奈特
．拉波波特
羅杰．
．伊拉甘
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197267A1 publication Critical patent/HK1197267A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
HK14110826A 2008-11-12 2014-10-29 分離的腎細胞及其用途 HK1197267A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11403008P 2008-11-12 2008-11-12
US11402508P 2008-11-12 2008-11-12
US20105608P 2008-12-05 2008-12-05
US20130508P 2008-12-08 2008-12-08
US12131108P 2008-12-10 2008-12-10

Publications (1)

Publication Number Publication Date
HK1197267A1 true HK1197267A1 (zh) 2015-01-09

Family

ID=41625133

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11111451.6A HK1157190A1 (en) 2008-11-12 2011-10-25 Isolated renal cells and uses thereof
HK14110826A HK1197267A1 (zh) 2008-11-12 2014-10-29 分離的腎細胞及其用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK11111451.6A HK1157190A1 (en) 2008-11-12 2011-10-25 Isolated renal cells and uses thereof

Country Status (10)

Country Link
US (5) US8318484B2 (zh)
EP (3) EP2662440B1 (zh)
JP (5) JP5974233B2 (zh)
KR (6) KR102357077B1 (zh)
CN (2) CN103937737B (zh)
AU (5) AU2009314552B2 (zh)
CA (1) CA2743459A1 (zh)
HK (2) HK1157190A1 (zh)
NZ (2) NZ593207A (zh)
WO (1) WO2010056328A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2725502T3 (es) 2007-06-08 2019-09-24 Univ Wake Forest Health Sciences Terapia celular selectiva para el tratamiento de la insuficiencia renal
US10590391B2 (en) 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
JP5974233B2 (ja) 2008-11-12 2016-08-24 リージェンメド（ケイマン）エルティーディー． 単離した腎細胞およびその使用
EP2499490A1 (en) 2009-11-12 2012-09-19 Tengion, Inc. Rational design of regenerative medicine products
JP5974215B2 (ja) * 2010-05-12 2016-08-24 リージェンメド（ケイマン）エルティーディー． 生理活性腎臓細胞
EP2637711B1 (en) * 2010-11-10 2024-03-27 ProKidney Injectable formulations for organ augmentation
JP2014532431A (ja) * 2011-11-04 2014-12-08 テンジオン， インク． 薬物スクリーニングおよび有効性アッセイ
NZ741724A (en) 2012-10-24 2020-02-28 Inregen Renal cell populations and uses thereof
AU2014209218B2 (en) * 2013-01-25 2018-06-07 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
US20160101133A1 (en) * 2013-05-08 2016-04-14 Regenmedtx, Llc Organoids comprising isolated renal cells and use thereof
IL298356B2 (en) * 2015-11-06 2024-09-01 Ventana Med Syst Inc Representative diagnostics
BR112019001409B1 (pt) * 2016-07-29 2022-03-03 Deepak Jain Uso de uma composição compreendendo uma população de células renais selecionadas para o tratamento de doença renal crônica
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
KR102771727B1 (ko) * 2017-06-21 2025-02-26 티모시 에이. 버트람 신장 질환의 치료를 위한 면역특권화 생체활성 신장 세포
CN108251352B (zh) * 2018-02-01 2021-07-06 伯仕利生物科技发展（盐城）有限公司 一种血管内皮干细胞的培养方法
CA3174551A1 (en) * 2020-03-04 2021-09-10 Metcela Inc. Fibroblast having enhanced erythropoietin production ability
WO2021176420A1 (en) 2020-03-06 2021-09-10 ReGenesys BVBA Biocompatible scaffolds for culturing post natal progenitor cells
CN112107600B (zh) * 2020-10-26 2024-04-05 张哲� 一种治疗色素沉着性疾病的纳米制剂及其制备方法
CN114703120B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统血管平滑肌细胞单细胞的分离方法
CN114507642B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统周细胞单细胞的分离方法
AU2023300371A1 (en) * 2022-06-29 2025-02-06 Timothy A. Bertram Selected renal cell populations, characteristics and uses thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US4769037A (en) 1986-10-28 1988-09-06 Midcalf Robert J Artificial replacement kidney implant and method of dialyzing blood
GB8722854D0 (en) 1987-09-29 1987-11-04 Hardy S M Implantable artificial kidney
US5085629A (en) 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
CN1053698C (zh) 1989-01-19 2000-06-21 南京大学 细胞培养生产促红细胞生成素的方法
WO1990012604A1 (en) 1989-04-25 1990-11-01 Vacanti Joseph P Method for implanting large volumes of cells on polymeric matrices
US4996154A (en) 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
WO1993007913A1 (en) 1991-10-24 1993-04-29 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
PT101031B (pt) 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US5429938A (en) 1992-03-02 1995-07-04 University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US6060270A (en) 1992-03-02 2000-05-09 The University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US6410320B1 (en) 1992-03-02 2002-06-25 The University Of Michigan Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5549674A (en) 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US5545131A (en) 1994-04-28 1996-08-13 White Eagle International Technologies, Lp Artificial kidney
EP0929271B1 (en) * 1996-09-05 2004-02-25 Children's Medical Center Corporation Prosthetic kidney
US6673339B1 (en) * 1996-09-05 2004-01-06 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
US5952226A (en) 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
KR100366689B1 (ko) * 1996-12-19 2003-01-06 하이닉스 세미컨덕터 아메리카 인코포레이티드 비디오 프레임 렌더링 엔진
US5854006A (en) * 1997-03-28 1998-12-29 The University Of Virginia Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP2004155788A (ja) * 1998-09-24 2004-06-03 Tanabe Seiyaku Co Ltd 腎疾患治療薬およびそのスクリーニング方法
US6777205B1 (en) 1998-11-06 2004-08-17 Sterrenbeld Biotechnologie North America, Inc. Host cells expressing recombinant human erythropoietin
JP2003523940A (ja) 1999-05-11 2003-08-12 オーソ−マクネイル ファーマシューティカル インコーポレイテッド エリスロポエチン投与の薬物速度論的および薬力学的モデリング
US20040167634A1 (en) 1999-05-26 2004-08-26 Anthony Atala Prosthetic kidney and its use for treating kidney disease
DE60043152D1 (de) 1999-05-27 2009-11-26 Cmic Co Ltd Heilmittel für nierenkrankheiten und verfahren zum screenen selbiger
KR100369788B1 (ko) 1999-09-03 2003-01-29 동아제약 주식회사 재조합 인간 에리트로포이에틴의 제조방법
US6376244B1 (en) 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US7326570B2 (en) 2000-06-16 2008-02-05 The Regents Of The University Of California Induction of tubular morphogenesis using pleiotrophin
CA2416126C (en) * 2000-07-28 2011-07-05 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
CA2427143A1 (en) * 2000-10-30 2002-08-08 Zymogenetics, Inc. Compositions and methods for improving kidney function
WO2002061053A1 (en) 2001-01-31 2002-08-08 The General Hospital Corporation Renal stem cells and uses thereof
GB2392116A (en) 2001-05-31 2004-02-25 Asahi Chemical Ind Method of separating and concentrating cells for kidney regeneration
US6784154B2 (en) 2001-11-01 2004-08-31 University Of Utah Research Foundation Method of use of erythropoietin to treat ischemic acute renal failure
AU2002340463A1 (en) * 2001-11-16 2003-06-10 Children's Medical Center Corporation Augmentation of organ function
US20030180268A1 (en) 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
CN100341496C (zh) 2002-03-22 2007-10-10 橘生药品工业株式会社 预防或治疗肾脏疾病的药剂
US8084424B2 (en) 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
US20060153894A1 (en) * 2004-06-30 2006-07-13 Ragae Ghabrial Multi-compartment delivery system
WO2006055412A1 (en) * 2004-11-19 2006-05-26 Shiva Biomedical, Llc Methods of treating erythropoietin-resistance
AU2006292203A1 (en) 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
CN102389344B (zh) * 2006-02-07 2015-12-16 脊柱赛特有限公司 采用机械应变使人皮肤成纤维细胞发生软骨形成分化的方法
WO2007095193A2 (en) 2006-02-10 2007-08-23 Tengion, Inc. Scaffolds for organ reconstruction and augmentation
JPWO2007125916A1 (ja) * 2006-04-24 2009-09-10 株式会社ステムセル研究所 移植用臓器の調製方法
DK2078073T3 (da) 2006-10-12 2013-10-28 Ethicon Inc Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering
EP2082064B1 (en) 2006-11-16 2011-10-05 Genentech, Inc. Genetic variations associated with tumors
EP2094850B1 (en) 2006-12-01 2013-06-12 Agency for Science, Technology And Research Cancer-related protein kinases
US10590391B2 (en) 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
US9580688B2 (en) 2007-06-08 2017-02-28 Wake Forest University Health Sciences Kidney structures and methods of forming the same
ES2725502T3 (es) 2007-06-08 2019-09-24 Univ Wake Forest Health Sciences Terapia celular selectiva para el tratamiento de la insuficiencia renal
JP5974233B2 (ja) 2008-11-12 2016-08-24 リージェンメド（ケイマン）エルティーディー． 単離した腎細胞およびその使用
JP5565607B2 (ja) 2009-07-15 2014-08-06 国立大学法人 東京大学 敗血症又は多臓器不全の予後診断方法及び予後診断用キット

Also Published As

Publication number Publication date
JP2018148909A (ja) 2018-09-27
AU2019202099A1 (en) 2019-04-18
US20130149347A1 (en) 2013-06-13
AU2009314552A1 (en) 2011-06-30
EP2662440B1 (en) 2018-04-25
JP2021100428A (ja) 2021-07-08
JP7625287B2 (ja) 2025-02-03
KR102672712B1 (ko) 2024-06-07
CN102271692B (zh) 2014-05-21
US9192629B2 (en) 2015-11-24
EP3388509A1 (en) 2018-10-17
AU2017202897B2 (en) 2019-04-18
AU2017202897A1 (en) 2017-05-25
NZ593207A (en) 2012-10-26
JP2023100876A (ja) 2023-07-19
AU2020239736A1 (en) 2020-10-15
KR101893717B1 (ko) 2018-08-30
KR20200138830A (ko) 2020-12-10
US20240108657A1 (en) 2024-04-04
CN103937737A (zh) 2014-07-23
WO2010056328A9 (en) 2011-05-19
HK1157190A1 (en) 2012-06-29
US20160206659A1 (en) 2016-07-21
EP2358375A1 (en) 2011-08-24
US10105392B2 (en) 2018-10-23
AU2019202099B2 (en) 2020-10-08
KR20170045385A (ko) 2017-04-26
KR102357077B1 (ko) 2022-01-27
KR20180097788A (ko) 2018-08-31
JP5974233B2 (ja) 2016-08-24
KR102428795B1 (ko) 2022-08-04
CN103937737B (zh) 2023-05-23
CA2743459A1 (en) 2010-05-20
WO2010056328A1 (en) 2010-05-20
KR20240091315A (ko) 2024-06-21
KR20110100213A (ko) 2011-09-09
AU2020239736B2 (en) 2024-02-08
AU2009314552B2 (en) 2017-02-02
JP2016028578A (ja) 2016-03-03
US20190117695A1 (en) 2019-04-25
US20110117162A1 (en) 2011-05-19
JP2012508691A (ja) 2012-04-12
NZ601862A (en) 2014-07-25
KR20220112862A (ko) 2022-08-11
CN102271692A (zh) 2011-12-07
EP2662440A1 (en) 2013-11-13
AU2024203036A1 (en) 2024-05-30
KR101735125B1 (ko) 2017-05-15
EP2358375B1 (en) 2013-07-24
US8318484B2 (en) 2012-11-27

Similar Documents

Publication Publication Date Title
HK1197267A1 (zh) 分離的腎細胞及其用途
GB0720484D0 (en) Cells
TWI370552B (en) Solar cell
EP2262038A4 (en) Cell selector and cell with it
GB0718577D0 (en) Fuel cells
IL203819A (en) Solar cell structure
EP2200112A4 (en) CELL ARRANGEMENT
GB0718349D0 (en) Fuel cells
IL201102A0 (en) Fast serving cell change
AU315795S (en) Battery
EP2226623A4 (en) FLOW CELL
EP2262039A4 (en) Cell selector and cell with it
HK1138939A1 (en) Solar cell
HK1154651A1 (zh) 稱重傳感器
PL2206157T3 (pl) Ogniwo słoneczne
GB0813669D0 (en) Electrolyte
GB0708030D0 (en) Solar cell
GB2440366B (en) Solar cells
GB0807693D0 (en) Photovoltaic cell
GB0823441D0 (en) Photovoltaic cell
PL2132808T3 (pl) Bateria
GB0718490D0 (en) Biodiesel
GB0817240D0 (en) Modified bacterial cell
EP2226622A4 (en) FLOW CELL
GB0714742D0 (en) Battery arrangement